Skip to content
AdminDec 11, 2018< 1 min read

US FDA's Scott Gottlieb says real-world data is 'top strategic priority’

U.S. Food and Drug Administration commissioner Scott Gottlieb announced that the agency would begin taking a more active role in applying patient data outside of clinical trials, known as real-world data, to drug regulation and approval.

Read More

RELATED ARTICLES